Presentation TCT 2015 Essentials of Quality and Compliance in Research Presenter: Kate Dalton October 11, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)? Presenter: Ori Ben-Yehuda October 11, 2015 More slides + Presentation TCT 2015 Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time! Presenter: Gary S. Roubin October 14, 2015 Presentation TCT 2015 Reversal Agents for Factor Xa Inhibitors Presenter: Lisa K. Jennings October 14, 2015 We Recommend
Presentation TCT 2015 PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)? Presenter: Ori Ben-Yehuda October 11, 2015
Presentation TCT 2015 Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time! Presenter: Gary S. Roubin October 14, 2015
Presentation TCT 2015 Reversal Agents for Factor Xa Inhibitors Presenter: Lisa K. Jennings October 14, 2015